Loading...

PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC Management Changes 8-K Filing

PCFC

PCB

PACIFIC BIOSCIENCES OF CALIFORNIA INC

(PACB)

2024 8-K

Management Changes

Board Appointment

Financial Results Announced

Management Changes

Asset Sale Completed

Financial Results Update

Third Quarter Results

Financial Statements

Financial Statements

Workforce Reductions

Management Change

Lease Amendment

Financial Results

Management Changes

Financial Update

Executive Changes

Management Change

Management Change

Management Change

Financial Results

Debt Exchange Agreement

Expense Reduction Plan

Financial Results Announcement

Equity Incentive Plan Amend...

Financial Results Announcement

Financial Update

Financial Results Announcement

Financial Results Announcement

Resignation of Director

Financial Results Announcement

Appointment of Director and...

Appointment of Director

Financial Results and Acqui...

Exchange of Convertible Sen...

Agreement and Exchange Tran...

Annual Meeting Voting Results

Financial Results Announcement

Financial Results Announcement

Agreement for Stock Offering

Financial Update

External Links:

Pacific Biosciences announced that Jeff Eidel will leave his role as Chief Commercial Officer on November 15, 2024, as part of an internal restructuring, with his duties being reassigned to CEO Christian Henry without a pay increase for Henry.

AI Assistant

PACIFIC BIOSCIENCES OF CALIFORNIA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.